Clearside Biomedical, Inc. — Director's Dealing 2019

Nov 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2019-11-12

Reporting Person: Deignan Charles A. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-12	Common Stock	P	7500	$1.14	Acquired	203856	Direct

Footnotes

F1: The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $1.13 to $1.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.